Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590993 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging and Spectroscopy of the Prostate
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,005
- Enrollment target
NCT00590993: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00590993 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,005 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00590993 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,005 participants
- Enrollment target
Study Summary
Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.
Interventions
- OTHER MRI and MRSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,005 participants |
| Start Date | 2000-12 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590993
The ClinicalTrials.gov registry entry for NCT00590993 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,005 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI and MRSI is the first listed.
NCT00590993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590993 about?
NCT00590993 is a clinical study titled "Magnetic Resonance Imaging and Spectroscopy of the Prostate". Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks...
What is the current status of trial NCT00590993?
This trial is currently completed. The enrollment target is 1,005 participants. The study started on 2000-12. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00590993?
The interventions under investigation include: MRI and MRSI (OTHER).
Who is sponsoring clinical trial NCT00590993?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.